Loading...
Market
Story
NHS Launches RSV Vaccine for First Time in UK for Babies and Elderly
Sep 2, 2024, 06:41 AM
The NHS has begun rolling out a new vaccine to combat the Respiratory Syncytial Virus (RSV), targeting vulnerable groups including babies, pregnant women, and the elderly. This marks the first time in NHS history that a vaccine specifically for RSV is offered, a common respiratory condition that can be severe in young children and older adults. The initiative aims to protect thousands of people across the UK, with the vaccine now available in England and Wales. Public Health Minister Gwynne MP highlighted the importance of the vaccine by sharing a personal story about his grandson's severe RSV case, emphasizing the potential to save thousands of lives. Professor Openshaw is expected to discuss the rollout.
View original story
Similar markets
Prevention of hospitalization • 25%
Employer or insurance requirements • 25%
Public health campaigns • 25%
Other • 25%
London • 25%
Midlands • 25%
North West • 25%
South East • 25%
Northeast • 25%
Midwest • 25%
South • 25%
West • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Northeast • 25%
Midwest • 25%
South • 25%
West • 25%
Ivory Coast • 25%
Ghana • 25%
Nigeria • 25%
Burkina Faso • 25%
England • 25%
Scotland • 25%
Wales • 25%
Northern Ireland • 25%
England highest • 25%
Wales highest • 25%
Scotland highest • 25%
Northern Ireland highest • 25%
Pfizer's ABRYSVO® • 25%
GSK's RSV vaccine • 25%
Moderna's RSV vaccine • 25%
Other • 25%
Moderna • 25%
Pfizer/BioNTech • 25%
Novavax • 25%
Other • 25%
65-74 • 25%
75-84 • 25%
85 and older • 25%
Immunocompromised individuals • 25%
London • 25%
Manchester • 25%
Birmingham • 25%
Other • 25%